A population-based genome-first approach for identification of P/LP TTR gene variants has the potential to diagnose cases of previously unrecognized ATTR and identify patients at risk for developing hATTR cardiomyopathy or polyneuropathy. The gene discussed is TTR; the disease is polyneuropathy.